1-8 of 8
Lei Wang, PhD.
Close
Sort by
Journal Articles

Tumor Microenvironment Associated with Complete Response to Tislelizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma Reveals a Potentially Different Mechanism of Action

Yuqin Song, MD PhD, Quanli Gao, MD, Lei Fan, MD PhD, Dehui Zou, MD, Huilai Zhang, MD PhD, Jianfeng Zhou, MD PhD, Wei Li, MD, Haiyan Yang, MD PhD, Ting Liu, MD PhD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Dan Wang, PhD, Pei Zhang, PhD, Tengfei Liu, PhD, Yun Zhang, PhD, Zhirong Shen, PhD, Lei Wang, PhD, Liudi Yang, MD, Haiyi Guo, MD, Jun Zhu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-136696
Published: 2020
Journal Articles

Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial Results from the PILOT Study

Alison R. Sehgal, MD, John Godwin, John Pribble, Lei Wang, PhD, Jerill Thorpe, BSc, Gerhard C. Hildebrandt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2882.
https://doi.org/10.1182/blood-2019-127658
Published: 2019
Journal Articles

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

Carlos R. Bachier, MD, Maria Lia Palomba, MD, Jeremy S. Abramson, MD MMSc, Charalambos Andreadis, MD MSCE, Alison R. Sehgal, MD, John Godwin, Gerhard C. Hildebrandt, MD, Tanya Siddiqi, MD, Don Stevens, MD, Thalia Farazi, Ana Kostic, Nikolaus S. Trede, Lei Wang, PhD, James Lymp, PhD, Tennille Thelen, Ken Ogasawara, David G. Maloney, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2868.
https://doi.org/10.1182/blood-2019-127566
Published: 2019
Journal Articles

TRANSCEND: Lisocabtagene Maraleucel (liso-cel; JCAR017) Healthcare Resource Utilization in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

M. Lia Palomba, MD, Jacob Garcia, MD, Lei Wang, PhD, Christine Dehner, Karen C. Chung, PharmD, MS, David G. Maloney, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3545.
https://doi.org/10.1182/blood-2018-99-119387
Published: 2018
Journal Articles

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Hiroshi Nishihara, MD., PhD., Lei Wang, PhD., Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Masato Obara, MD, PhD, Shinya Tanaka, MD., PhD.
Journal: Blood
Blood (2011) 118 (21): 5230.
https://doi.org/10.1182/blood.V118.21.5230.5230
Published: 2011
Journal Articles

Mobilization of Hematopoitic Stem/Progenitor Cells by a Cdc42 Activity-Specific Inhibitor

Wei Liu, MD, MS, Lei Wang, PhD, Xun Shang, PhD, Fukun Guo, PhD, Marnie A. Ryan, PhD, Hartmut Geiger, PhD, Yi Zheng, PhD
Journal: Blood
Blood (2008) 112 (11): 68.
https://doi.org/10.1182/blood.V112.11.68.68
Published: 2008
Journal Articles

Defective Adhesion, Migration and Homing Are Associated with Altered Rho GTPase Activity in Cells from Fanconi Anemia Patients.

Xiaoling Zhang, MD, Xun Shang, PhD, Lei Wang, PhD, Fukun Guo, PhD, Yi Zheng, PhD, Qishen Pang, PhD
Journal: Blood
Blood (2006) 108 (11): 350.
https://doi.org/10.1182/blood.V108.11.350.350
Published: 2006
Journal Articles

A Critical Role of the Rho Family GTPase Cdc42 in Hematopoietic Stem Cell Mobilization, Homing, Engraftment and Differentiation.

Linda Yang, MS, Lei Wang, PhD, Jose A. Cancelas, MD, PhD, David A. Williams, MD, Yi Zheng, PhD
Journal: Blood
Blood (2005) 106 (11): 269.
https://doi.org/10.1182/blood.V106.11.269.269
Published: 2005